Stomach Cancer DrugsMarket
- 2026 年市場規模
- USD 5,600 Mn
- 2033 年預估規模
- USD 9,100 Mn
- 年複合成長率 CAGR
- 7.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Stomach Cancer DrugsMarket, By Therapy Type (Kinase Inhibitors, Nucleoside Metabolic Inhibitors, Anthracyclines, Microtubule Inhibitors, VEGF Antibodies, HER2 Receptor Antagonists, Car T Cell Therapy), By Application (Adenocarcinomas, Gastrointestinal Stromal Tumors and Carcinoid Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Stomach cancer is the fifth most common cancer globally regardless of gender as reported by the World Cancer Research Fund (WCRF) in 2018. There are many factors which cause stomach cancer such as unhealthy diet, smoking, obesity, alcohol, and Helicobacter pylori infection. According to the Cancer Research U.K. data of 2016, one out of three stomach cancer cases is related to Helicobacter pylori infection in the U.K. annually. Stomach cancer tests identify the stage of the cancer and the patient is treated accordingly. Targeted drug therapies are frequently used to treat stomach cancer as these drugs target the rapidly dividing cells and have less side effects. Drugs that target HER2 are under developmental studies to treat advanced stomach cancer. For instance, pertuzumab in combination with trastuzumab and chemotherapy is under phase 3 clinical trials to treat metastatic gastroesophageal junction or gastric cancer.
Market Dynamics
Increasing prevalence of stomach cancer worldwide is expected to boost the stomach cancer drugs market size. For instance, according to WCRF data of 2018, around one million cases of stomach cancer were diagnosed in 2018. Furthermore, increasing geriatric population is at a high risk of developing stomach cancer and men are more vulnerable to developing stomach cancer. For instance, according to the American Cancer Society (ACS) report in 2014, the average age of people diagnosed with stomach cancer is 68. As per the same source, six out of ten people diagnosed with stomach cancer annually are 65 or older, and stomach cancer is the fourth most common cancer in men.
However, the major challenge in the stomach cancer drugs market are the high expenses related to treatment of stomach cancer, which are not affordable to the middle to low income families in most countries. According to a data published in Oncotarget (impact journal) in 2017, the cost of stomach cancer drugs (considering Trastuzumab) can reach up to US$ 8,000 for four weeks and annually it can reach up to US$ 96,000.
Key features of the study
• This report provides in-depth analysis of the stomach cancer drugs market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global stomach cancer drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players include Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline Plc., Kuhnil Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Merck KGaA, AstraZeneca Plc, Otsuka Holdings Co. Ltd., Sanofi S.A., and F. Hoffmann-La Roche Ltd, Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb (BMS), Jiangsu HengRui Medicine Co. Ltd., Gilead Science Inc., Celgene Corporation, Taiho Pharmaceutical, Boston Biomedical Inc., and Merck & Co.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, government initiatives, technological up-gradation, market expansion, and marketing tactics
• The global stomach cancer drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for stomach cancer drugs market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• Therapy Type Insights (Revenue, USD Mn, 2026 - 2033)
o Kinase Inhibitors
o Nucleoside Metabolic Inhibitors
o Anthracyclines
o VEGF Antibodies
o HER2 Receptor Antagonists
o Car T Cell Therapy Trastuzumab
o Trastuzumab
• Application Insights (Revenue, USD Mn, 2026 - 2033)
o Adenocarcinomas
o Gastrointestinal Stromal Tumors
o Carcinoid Tumors
• Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
o Endoscopic Surgery
o Surgical Suite
o Dental Surgery
o Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players Insights
o Pfizer Inc.
o Eli Lilly and Company
o GlaxoSmithKline Plc.
o Kuhnil Pharmaceutical Co. Ltd.
o Daiichi Sankyo Co. Ltd.
o Merck KGaA
o AstraZeneca Plc.
o Otsuka Holdings Co. Ltd.
o Sanofi S.A.
o F. Hoffmann-La Roche Ltd.
o Ono Pharmaceutical Co. Ltd.
o Bristol-Myers Squibb (BMS)
o Jiangsu HengRui Medicine Co. Ltd.
o Gilead Science Inc.
o Celgene Corporation
o Taiho Pharmaceutical
o Boston Biomedical Inc.
o Merck & Co.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Global Stomach Cancer Drugs Market, By Therapy Type
Global Stomach Cancer Drugs Market, By Application
Global Stomach Cancer Drugs Market, By Distribution Channel
Global Stomach Cancer Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trend
4. Global Stomach Cancer Drugs Market, By Therapy Type, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Kinase Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Nucleoside Metabolic Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Anthracyclines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o VEGF Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o HER2 Receptor Antagonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Car T Cell Therapy Trastuzumab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Trastuzumab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
5. Global Stomach Cancer Drugs Market, By Application, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Adenocarcinomas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Gastrointestinal Stromal Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Carcinoid Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
6. Global Stomach Cancer Drugs Market, By Distribution Channel, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
7. Global Stomach Cancer Drugs Market, By Region, 2020 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Therapy Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Value (USD Mn)
Market Size and Forecast, By Therapy Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
8. Competitive Landscape
o Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Eli Lilly and Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o GlaxoSmithKline Plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Kuhnil Pharmaceutical Co. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Daiichi Sankyo Co. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o AstraZeneca Plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Otsuka Holdings Co. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o F. Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Ono Pharmaceutical Co. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bristol-Myers Squibb (BMS)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Jiangsu HengRui Medicine Co. Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Gilead Science Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Celgene Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Taiho Pharmaceutical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Boston Biomedical Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck & Co.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們